Author(s): Priya P. Munshi, D.S. Mohale, R. Akkalwar, A.V. Chandewar

Email(s): priyamunshi09@gmail.com , priyamunshi09@rediffmail.com

DOI: Not Available

Address: Priya P. Munshi*, D.S. Mohale, R. Akkalwar and A.V. Chandewar
Department of Quality assurance, P. Wadhwani College of Pharmacy, Yavatmal - 445001.
*Corresponding Author

Published In:   Volume - 4,      Issue - 9,     Year - 2011


ABSTRACT:
It is phynyl acitic acid derivative developed as anti-inflammatory agent. It has analgesic anti-inflammatory antipyretic like actions like other NSAIDS. . It is recommended in long term treatment of rheumatoid arthritis, osteoarthritis and ankylosing spondylitis. It is also useful acute mescuskelatal disorder post operative pain and dysmenorrhoea Diclofenac sodium gel were developed in seven different formulations (F1 to F7) by employing different grades of polymers such as Hpmck4m and Crbopol940. There the various Diclofenac gels are available in market.but the propose gel is formulated with two key ingredients oleoresin, and l linseed oil contribute to anti-inflammatory effect. The formulations were evaluated for various physical parameters, ph spredibility , drug relese excrutability studies drug released mechanisms.B7formulation showed maximum drug releaseof 8 hours and maximum drug. Finally the gel formulations found to be economical and may overcome the draw backs associated with the drug during its absorption.


Cite this article:
Priya P. Munshi, D.S. Mohale, R. Akkalwar, A.V. Chandewar. Formulation and Evaluation of Diclofenac gel. Research J. Pharm. and Tech. 4(9): Sept. 2011; Page 1394-1399.

Cite(Electronic):
Priya P. Munshi, D.S. Mohale, R. Akkalwar, A.V. Chandewar. Formulation and Evaluation of Diclofenac gel. Research J. Pharm. and Tech. 4(9): Sept. 2011; Page 1394-1399.   Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2011-4-9-2


Recomonded Articles:

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.5958/0974-360X 

1.3
2021CiteScore
 
56th percentile
Powered by  Scopus


SCImago Journal & Country Rank

Journal Policies & Information


Recent Articles




Tags


Not Available